₹ 472.80
9.25 (2.00%)
B
Bafna Pharmaceuticals
₹ 472.80
Bafna Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Bafna Pharmaceuticals as of Q2 Sep 2019 stands at ₹-0.25. This is a 72.22% growth quarter on quarter. For the FY2020 the EPS of Bafna Pharmaceuticals stands at ₹-15.52. This is a 35.19% fall compared with FY2019.
Bafna Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

